Statin Compliance of Patients With Non-insulin-dependent Diabetes (DIOS)

Lille Catholic University

Status: Terminated

Conditions: Non-insulin-dependent Diabetes

Treatments: Other: Girerd test

Study type: Observational

Funder types: Other

Identifiers

NCT04007133

RC-P0064

Details and patient eligibility

About

The diabetic population has an increased cardiovascular risk compared to the general population.

Hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase) inhibitors, or "statins", are considered as the standard treatment for hypercholesterolemia.

Many patients with non-insulin-dependent diabetes are prescribed with statins, both for primary prevention, before the first cardiovascular event, and as secondary prevention, to avoid recurrence.

However, compliance to these drugs may be difficult due to polypharmacy, side effects (myalgia) or tiredness.

The purpose of this study is to determine the compliance of diabetic patients with statins searching for important factors which could favor adherence.

Full description

The diabetic population has an increased cardiovascular risk compared to the general population. The mortality of people with diabetes due to ischemic heart disease is multiplied by 2.2, and when is due to cerebrovascular disease by 1.8 compared to those patients without diabetes. Hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase) inhibitors, or "statins", are considered as the standard treatment for hypercholesterolemia.

Statins have been shown to be effective in reducing the risk of cardiovascular events, each 1 mmol decrease in LDL cholesterol reduces the risk of cardiovascular events by 21% at 5 years.

Many patients with non-insulin-dependent diabetes are prescribed with statins, both for primary prevention, before the first cardiovascular event, and for secondary prevention, to avoid recurrence.

However, compliance with these drugs may be difficult due to polypharmacy, side effects (myalgia) or tiredness. Indeed, the persistence of statin use, one year after its prescription, is estimated at 70% in the general population. However, there are no data in the French population, and in particular on French diabetic patients for whom the cardiovascular risk is increased compared to the general population.

The purpose of this study is to determine the compliance of diabetic patients with statins searching for important factors which could favor adherence.

Enrollment: 119 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Major patients
• With non-insulin-dependent diabetes, taking statins for at least 1 month (to assess compliance)
• Hospitalized in the Diabetology Day Hospital of the Saint Philibert Hospital
• In capacity to answer the Girerd test
• Patient who has been informed and not opposed to the study

Exclusion criteria

• Patient's refusal to participate in the study
• Patient under guardianship or curatorship

Trial design

119 participants in 1 patient group

Diabetic patients

Description:

Patients with non-insulin-dependent diabetes, taking statins for at least 1 month

Treatment:

Other: Girerd test